Identification | Back Directory | [Name]
Vicriviroc Malate | [CAS]
541503-81-5 | [Synonyms]
CS-599 Vicriviroc Malate 1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]-4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methylpiperidine malate | [Molecular Formula]
C32H44F3N5O7 | [MDL Number]
MFCD14635362 | [MOL File]
541503-81-5.mol | [Molecular Weight]
667.716 |
Hazard Information | Back Directory | [Definition]
ChEBI: (4,6-Dimethylpyrimidin-5-yl)-[4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl]methanone;2-hydroxybutanedioic acid is a member of (trifluoromethyl)benzenes. | [target]
CCR5 |
|
Company Name: |
NCE Biomedical Co.,Ltd.
|
Tel: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
Website: |
www.is0513.com/ShowSupplierProductsList15748/0.htm |
Company Name: |
SPIRO PHARMA
|
Tel: |
|
Website: |
www.spiropharma.com.cn |
|